Teladoc Health highlights its “misleading” adjusted EBITDA numbers but the true cash flows of the business reveal growing losses and the business is not as rosy as management would have investors believe, Forbes contributor David Trainer, who is the CEO of independent research firm New Constructs, says. According to Trainer, using adjusted EBITDA allows the company to present itself as profitable and lets executives keep earning bonuses “even as they destroy shareholder value.”
https://thefly.com/landingPageNews.php?id=2883811
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.